{"pmid":32397803,"title":"Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.","text":["Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.","Eur J Prev Cardiol","Sciatti, Edoardo","Ceconi, Claudio","32397803"],"journal":"Eur J Prev Cardiol","authors":["Sciatti, Edoardo","Ceconi, Claudio"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397803","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/2047487320925622","topics":["Prevention","Treatment"],"weight":1,"_version_":1666714494945984512,"score":9.490897,"similar":[{"pmid":32391719,"title":"Cardiovascular disease and COVID-19: les liaisons dangereuses.","text":["Cardiovascular disease and COVID-19: les liaisons dangereuses.","Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.","Eur J Prev Cardiol","Barison, Andrea","Aimo, Alberto","Castiglione, Vincenzo","Arzilli, Chiara","Lupon, Josep","Codina, Pau","Santiago-Vacas, Evelyn","Cediel, German","Emdin, Michele","Bayes-Genis, Antoni","32391719"],"abstract":["Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations."],"journal":"Eur J Prev Cardiol","authors":["Barison, Andrea","Aimo, Alberto","Castiglione, Vincenzo","Arzilli, Chiara","Lupon, Josep","Codina, Pau","Santiago-Vacas, Evelyn","Cediel, German","Emdin, Michele","Bayes-Genis, Antoni"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391719","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/2047487320924501","keywords":["covid-19","coronavirus","sars-cov-2","cardiovascular","comorbidities","risk factors"],"topics":["Treatment","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1666528580179329024,"score":172.10413},{"pmid":32370269,"title":"Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?","text":["Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?","We read with great interest the article by Brake SJ and colleagues [...].","J Clin Med","Li Volti, Giovanni","Caruso, Massimo","Polosa, Riccardo","32370269"],"abstract":["We read with great interest the article by Brake SJ and colleagues [...]."],"journal":"J Clin Med","authors":["Li Volti, Giovanni","Caruso, Massimo","Polosa, Riccardo"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32370269","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3390/jcm9051321","keywords":["covid-19","sars-cov-2","angiotensin-converting enzyme-2","smoking"],"topics":["Mechanism"],"weight":1,"_version_":1666138496316735490,"score":66.25463},{"pmid":32408724,"title":"COVID-19 in Europe: Le roi est mort, vive le roi!","text":["COVID-19 in Europe: Le roi est mort, vive le roi!","Neurospine","Stienen, Martin N","32408724"],"journal":"Neurospine","authors":["Stienen, Martin N"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32408724","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.14245/ns.2040202.105","weight":0,"_version_":1666897319183777792,"score":55.830013},{"pmid":32353251,"pmcid":"PMC7185942","title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation.","text":["COVID-19 cytokine storm: the interplay between inflammation and coagulation.","Lancet Respir Med","Jose, Ricardo J","Manuel, Ari","32353251"],"journal":"Lancet Respir Med","authors":["Jose, Ricardo J","Manuel, Ari"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353251","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/S2213-2600(20)30216-2","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495639355394,"score":50.767},{"pmid":32384917,"title":"COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.","text":["COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.","Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presently become a rapidly spreading and devastating global pandemic. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) may serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory compromise such as that induced by SARS-CoV-2. While still little is known on the true efficacy of ECMO in this setting, the natural resemblance of seasonal influenza's characteristics with respect to acute onset, initial symptoms, and some complications prompt to ECMO implantation in most severe, pulmonary decompensated patients. The present review summarizes the evidence on ECMO management of severe ARDS in light of recent COVID-19 pandemic, at the same time focusing on differences and similarities between SARS-CoV-2 and ECMO in terms of hematological and inflammatory interplay when these two settings merge.","Crit Care","Kowalewski, Mariusz","Fina, Dario","Slomka, Artur","Raffa, Giuseppe Maria","Martucci, Gennaro","Lo Coco, Valeria","De Piero, Maria Elena","Ranucci, Marco","Suwalski, Piotr","Lorusso, Roberto","32384917"],"abstract":["Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presently become a rapidly spreading and devastating global pandemic. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) may serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory compromise such as that induced by SARS-CoV-2. While still little is known on the true efficacy of ECMO in this setting, the natural resemblance of seasonal influenza's characteristics with respect to acute onset, initial symptoms, and some complications prompt to ECMO implantation in most severe, pulmonary decompensated patients. The present review summarizes the evidence on ECMO management of severe ARDS in light of recent COVID-19 pandemic, at the same time focusing on differences and similarities between SARS-CoV-2 and ECMO in terms of hematological and inflammatory interplay when these two settings merge."],"journal":"Crit Care","authors":["Kowalewski, Mariusz","Fina, Dario","Slomka, Artur","Raffa, Giuseppe Maria","Martucci, Gennaro","Lo Coco, Valeria","De Piero, Maria Elena","Ranucci, Marco","Suwalski, Piotr","Lorusso, Roberto"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32384917","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1186/s13054-020-02925-3","locations":["Veno"],"topics":["Treatment"],"weight":1,"_version_":1666340102006112258,"score":48.53906}]}